Latest Breaking News On - Helen rubinstein - Page 3 : comparemela.com

SAGE Therapeutics (SAGE) Reports Q1, Provides Pipeline and Business Progress

SAGE Therapeutics (SAGE) Reports Q1, Provides Pipeline and Business Progress
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Helen rubinsteinBarry greeneMatthew hensonSage therapeutics incEarly developmentEuropean medicines agencyExchange commissionNational pregnancy registry for antidepressantsAcademy of managed care pharmacy annual meetingWall streetChief executive officerBreakthrough therapyFast track designationPrescription drug user fee actManaged care pharmacy annual meetingOrphan drug designation

Sage Therapeutics and Biogen Share Update on FDA Advisory Committee for Zuranolone

Sage Therapeutics and Biogen Share Update on FDA Advisory Committee for Zuranolone
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomKathryn ritzingerMike henckeJack coxHelen rubinsteinDrug administrationBiogen incExchange commissionSage therapeutics incNew drug applicationPrescription drug user fee actPrivate securities litigation reform actSage therapeutics

Sage Therapeutics, Inc.: Sage Therapeutics Announces European Medicines Agency Granted SAGE-718 Orphan Drug Designation for the Treatment of Huntington's Disease

Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, today announced the European Medicines Agency (EMA) granted Orphan Drug

Dennis riedlHelen rubinsteinMatthew hensonLaura gaultExchange commissionSage therapeutics incEuropean medicines agencySage therapeuticsOrphan drug designationChief medical officerProtocol assistanceFast track designationPrivate securities litigation reform act

Sage Therapeutics, Inc. (NASDAQ:SAGE) Q4 2022 Earnings Call Transcript

Operator: Good morning. Welcome to the Sage Therapeutics Fourth Quarter and Full-Year 2022 Financial Results Conference Call. Currently, all participants are in a listen-only mode.

United statesChris benecchiKimi iguchiBarry greeneHelen rubinsteinJim dohertyTazeen ahmadLaura gaultSage therapeutics incHealth photoBrain healthSage therapeuticsCall transcript februarySage therapeutic fourth quarterResults conferenceInvestor relations

Sage Therapeutics and Biogen Announce FDA Accepts Filing of New Drug Application and Grants Priority Review of Zuranolone in the Treatment of Major Depressive Disorder and Postpartum Depression

Sage Therapeutics and Biogen Announce FDA Accepts Filing of New Drug Application and Grants Priority Review of Zuranolone in the Treatment of Major Depressive Disorder and Postpartum Depression
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomKathryn ritzingerCharles weissmannWalter gilbertHeinz schallerLaura gaultPriya singhalMike henckeJack coxHelen rubinsteinKenneth murrayHead of researchCommittee opinion noDrug administrationRegulatory sciences at biogen